Truist Financial raised its price objective and issued a buy rating for Elevance Health, Inc. on July 4, 2026.
4 reports, 2 independent
Updated Oct 13
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial raised its price objective and issued a buy rating for Elevance Health, Inc. on July 4, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Leerink and Truist both raised price targets for Elevance Health on Oct 8.1 source
Truist Financial raises rating for Elevance Health, Inc.1 source
Keep exploring
The entities involved
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
-
Elevance Health, Inc.
American healthcare company
Nothing else this week.
Related events
- Bank of America and Truist Financial reaffirmed and boosted buy ratings and price objectives for Arista Networks.
- Truist Financial set a price objective on Palvella Therapeutics, Inc., and a director sold shares of the company stock.
- Financial firms including Truist, RBC, TD Cowen, and Jefferies issued various rating updates on October 30, 2026.